Lundbeck
HLUN-B.CO
#2346
Rank
C$8.86 B
Marketcap
$9.16
Share price
0.98%
Change (1 day)
26.93%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total debt

Total debt on the balance sheet as of June 2024 : C$0.81 B

According to Lundbeck 's latest financial reports the company's total debt is C$0.81 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Lundbeck - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31C$0.81 B-25.21%
2022-12-31C$1.09 B6.31%
2021-12-31C$1.02 B-38.34%
2020-12-31C$1.66 B-10.66%
2019-12-31C$1.86 B
2018-12-31N/A-100%
2017-12-31C$11.55 M-96.8%
2016-12-31C$0.36 B-52.98%
2015-12-31C$0.76 B21.15%
2014-12-31C$0.63 B48.85%
2013-12-31C$0.42 B26.11%
2012-12-31C$0.33 B-0.84%
2011-12-31C$0.34 B-1.32%
2010-12-31C$0.34 B-51.11%
2009-12-31C$0.70 B61.43%
2008-12-31C$0.43 B22.17%
2007-12-31C$0.35 B20.89%
2006-12-31C$0.29 B318.01%
2005-12-31C$70.76 M-13.17%
2004-12-31C$81.5 M